Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK, and DDI of TBA-7371 in Healthy Subjects
NCT03199339Phase 1Completed
- Sponsor
- TB Alliance
- Start
- Aug 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of TBA-7371 in pulmonary tuberculosis (TB) (19 cohorts), sponsored by TB Alliance. Primary endpoint: Treatment Emergent Adverse Events. Started Aug 2017; status: completed.
02
Drugs
TBA-7371
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT03199339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03199339.